Topiramate for Irritability and Anger Management

Evidence on Efficacy for Irritability and Anger

Controlled studies in adults have not found topiramate to be helpful for mood disorders, and evidence in children and adolescents is equivocal 1, 2
While topiramate has been studied for bipolar disorder, the American Academy of Child and Adolescent Psychiatry does not recommend it as a primary treatment for mania or irritability 1
Some evidence suggests topiramate may have modest efficacy for alcohol dependence, which could indirectly affect irritability in that population 3

Standard therapy typically includes lithium, valproate, and/or atypical antipsychotic agents as first-line treatments for irritability and anger in the context of bipolar disorder, as recommended by the American Academy of Child and Adolescent Psychiatry 1
The American Academy of Child and Adolescent Psychiatry recommends FDA-approved medications for bipolar disorder, including lithium, aripiprazole, valproate, olanzapine, risperidone, quetiapine, and ziprasidone, as first-line treatments for acute mania in adults 2
Risperidone has demonstrated efficacy for irritability and aggression in children with intellectual disability, according to the American Academy of Child and Adolescent Psychiatry 4
Methylphenidate may be beneficial when irritability is associated with ADHD symptoms in children with intellectual disability, as suggested by the American Academy of Child and Adolescent Psychiatry 4

Absolute contraindications for topiramate include pregnancy or women who may become pregnant without reliable contraception, uncontrolled hypertension, history of cardiovascular disease, untreated hyperthyroidism, concomitant MAOI use or within 14 days of MAOI use, and history of significant nephrolithiasis, as stated by the American College of Obstetricians and Gynecologists and other relevant guideline societies 5
Common side effects of topiramate include cognitive impairment, paresthesia, and metabolic acidosis, which can be monitored and managed according to guidelines from the American Academy of Neurology and other relevant societies 5, 6

Regularly assessing serum bicarbonate levels is crucial due to the risk of metabolic acidosis associated with topiramate, as recommended by the American Academy of Clinical Toxicology and other relevant guideline societies 5
Monitoring blood pressure and heart rate, especially during initial titration, is essential when prescribing topiramate, according to guidelines from the American Heart Association and other relevant societies 5
For women of reproductive potential, monthly pregnancy tests are recommended when taking topiramate, as stated by the American College of Obstetricians and Gynecologists and other relevant guideline societies 5

Abrupt discontinuation of topiramate may increase seizure risk; tapering gradually if discontinuing is recommended by the American Academy of Neurology and other relevant guideline societies 6
Combination with other psychotropic medications may increase the risk of cognitive side effects, which can be managed according to guidelines from the American Psychiatric Association and other relevant societies 6
Metabolic acidosis can develop gradually and requires monitoring, as recommended by the American Academy of Clinical Toxicology and other relevant guideline societies 5